Hellebrigenin TN1728
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Hellebrigenin has anti-hepatoma activities, it induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt. Hellebrigenin exhibites moderate to strong activity against human HL-60, SF-295, MDA-MB-435, an
CAS nr:
465-90-7
Purity:
98%
Molecular Weight:
416,51
SMILES:
[H][C@@]12CC[C@]3(O)C[C@@H](O)CC[C@]3(C=O)[C@@]1([H])CC[C@]1(C)[C@H](CC[C@]21O)c1ccc(=O)oc1
Formula:
C24H32O6
Pathway:
DNA Damage/DNA Repair,Chromatin/Epigenetic,Cytoskeletal Signaling,PI3K/Akt/mTOR signaling,Cell Cycle/Checkpoint
Target:
PARP,PARP,Akt,Akt,CDK
